abstract |
The present invention concerns stable liquid pharmaceutical compositions comprising gamma interferon (IFN-η, also known as immune interferon). The invention specifically covers stabilized aqueous pharmaceutical compositions comprising multiple doses of a therapeutically effective amount of IFN-η for repeated administration. |